Ceftiofur
Systematic (IUPAC) name | |
---|---|
(6R,7R)-7-[ [(2Z)-2-(2-Amino-1,3-thiazol-4-yl)- 2-methoxyiminoacetyl]amino]-3-(furan-2- carbonylsulfanylmethyl)-8-oxo-5-thia-1- azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Legal status | ? |
Identifiers | |
CAS number | 80370-57-6 |
ATCvet code | QJ01DD90 QJ51DD90 |
PubChem | CID 6328657 |
ChemSpider | 4886668 |
UNII | 83JL932I1C |
KEGG | D07657 |
ChEMBL | CHEMBL222913 |
Chemical data | |
Formula | C19H17N5O7S3 |
Mol. mass | 523.56 g/mol |
SMILES
| |
| |
(what is this?) (verify) | |
Ceftiofur is an antibiotic of the cephalosporin type (third generation), licensed for use in veterinary medicine. It was first described in 1987.[1] It is marketed by pharmaceutical company Pfizer as Excenel,[2] and is the active ingredient in that company's Specramast LC (lactating cow formula) product.
It is resistant to the antibiotic resistance enzyme beta-lactamase, and has activity against Gram-positive and Gram-negative bacteria. E. coli strains resistant to ceftiofur have been reported.[3]
References
- ↑ Yancey RJ, Kinney ML, Roberts BJ, Goodenough KR, Hamel JC, Ford CW (1987). "Ceftiofur sodium, a broad-spectrum cephalosporin: evaluation in vitro and in vivo in mice". Am. J. Vet. Res. 48 (7): 1050–3. PMID 3631686.
- ↑ "Pfizer Animal Health Dairy Information on Products and Solutions". Retrieved 2007-11-20.
- ↑ Donaldson SC, Straley BA, Hegde NV, Sawant AA, DebRoy C, Jayarao BM (2006). "Molecular epidemiology of ceftiofur-resistant Escherichia coli isolates from dairy calves". Appl. Environ. Microbiol. 72 (6): 3940–8. doi:10.1128/AEM.02770-05. PMC 1489609. PMID 16751500.
External links
|